Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I trial of IMSUT-CORD for steroid-resistant severe acute graft-versus-host disease
jRCT2033180077Phase 1Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jul 2018
- Countries
- 1
01
Overview
Phase 1, open-label trial in Acute Graft-Versus-Host Disease (aGvHD) (3 cohorts), sponsored by Japan Agency for Medical Research and Development. Primary endpoints: Incidence of dose-limiting toxicity, Adverse events and 1 more. Started Jul 2018; status: completed.
02
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on jRCT2033180077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033180077.